导师风采
窦克非
个人信息
Personal Information
- 性别：男
- 导师类型：博士生导师
- 职称：主任医师
- 该职称任职时间：19970801
联系方式
Contact Information
- 所属院系：阜外医院
- 所属专业：
- 邮箱 : drdoukefei@126.com
- 工作电话 : 010-88396584
个人简介
Personal Profile
窦克非，博士，主任医师，博士研究生导师。 现任中国医学科学院阜外医院内科管委会主任，心血管代谢中心主任，冠心病中心副主任，冠心病五病房主任，心血管疾病国家重点实验室PI，国家临床医学研究中心PI。 2020年入选国家百千万人才工程，获有突出贡献中青年专家荣誉称号。 2023年入选国务院政府特殊津贴专家。 国家心血管病中心专家委员会心血管代谢医学专委会副主任委员兼秘书长，国家心血管病中心心血管代谢专病医联体理事长，中国心胸血管麻醉学会基层心血管医师分会主任委员，亚洲心脏学会介入心脏病分会副主席，中华医学会心血管病分会介入心脏病学组委员，北京医学会心血管病学分会委员。亚洲心脏学会（AHS）介入心脏病学委员会副主席，美国心血管造影与介入协会（FSCAI），美国心脏学会（FACC），欧洲心脏病学会（FESC）会员。 从事冠心病的临床、基础及介入治疗相关工作与研究。作为心脏介入医生累计完成冠心病介入诊断及治疗逾30000例，多次以第一术者在美国经导管心血管治疗年会（TCT）、欧洲心血管介入大会（EuroPCR）、亚太心血管介入大会（TCTAP）、中国介入心脏病学大学（CIT）、中国心脏大会（CHC）等国内外学术会议进行高难度手术示教演示。针对疑难复杂冠脉介入有很高造诣，尤其在治疗被誉为“冠脉介入治疗最后堡垒”的慢性完全闭塞（CTO）病变上，积累了丰富经验，是第一批获认证的“Hybrid CTO带教专家”（全国仅10人）。曾获评“2017年首都十大杰出青年医生”，“2018 年北京医师协会北京优秀医师”。
团队简介
Team Profile
待补充更新
- 研究方向Research Directions
冠脉介入风险预测模型、冠心病诊疗相关创新和转化、心血管代谢异常管理
- 在校研究生Current Graduate Students
硕士研究生 0 名，博士研究生 10 名
- 科研项目Research Projects
| # | 项目名称 | 起止日期 | 金额 | 项目类型 | 本人角色 |
|---|---|---|---|---|---|
| 1 | 评价冠状动脉冲击波碎石系统用于重度钙化冠脉病变预处理的安全性和有效性的前瞻性、多中心、单组目标值临床试验 | 2022-04-07 —— | 45万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 2 | 应用基线V-RESOLVE评分指导冠脉分叉病变介入治疗对降低分支血管闭塞率作用的研究 | 2020-06-05 —— | 70万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 3 | 吲哚在冠状动脉粥样硬化中的作用及机制的研究 | 2020-10-17 —— | 55万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 4 | 规范与精准血脂管理对国人动脉粥样硬化性心血管疾病防治效果的研究 | 2021-10-01 —— | 4000万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 5 | 基于多模态通信的全程辅助心血管介入机器人临床前研究 | 2022-04-12 —— | 150万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 6 | 药物洗脱球囊进行冠脉原发病变介入治疗术后的多中心研究 | 2021-09-18 —— | 80万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 7 | 注射用重组人胸腺素β4（NL005）用于急性心肌梗死患者的有效性和安全性IIa期临床研究 | 2020-08-10 —— | 76万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 8 | 石胆酸在冠状动脉粥样硬化中的作用及机制的研究 | 2018-09-03 —— | 57万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 9 | 应用V－RESOLVE评分指导冠脉分叉病变介入治疗对减少分支血管闭塞及围术期心肌梗死的前瞻性多中心群组随机对照研究 | 2021-10-01 —— | 35万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 10 | 冠状动脉高阻力病变激光消融介入治疗仪的研究及制造 | 2023-01 —— | 200万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 11 | 脂蛋白(a)升高患者经皮冠状动脉介入治疗术后延长双联抗血小板治疗对预后影响的前瞻性、多中心、随机对照研究 | 2024-01 —— | 150万元 | 主持在研的国家或省部级科研项目 | 主持者 |
| 12 | CorVad介入式心室辅助系统治疗高危PCI临床试验 | 2023-01 —— | 140万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 13 | 评价紫杉醇药物涂层冠状动脉球囊扩张导管治疗冠脉支架内再狭窄患者的 安全性和有效性的前瞻性、多中心、随机对照临床试验 | 2024-01 —— | 245万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 14 | ZEUS-ziltivekimab 对比安慰剂对确诊动脉粥样硬化性心血管疾病合并慢性肾脏病和系统性炎症受试者心血管结局的作用 | 2024-01 —— | 72万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 15 | CorVad介入式心室辅助系统前瞻性、多中心、单组临床试验 | 2023-01 —— | 107万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 16 | 通过光学相干断层扫描技术（OCT）评价冠脉狭窄或阻塞患者植入三氧化二砷药物涂层支架与左他莫司药物涂层支架的内皮愈合情况的前瞻性、多中心、随机对照研究上市后临床研究 | 2022-01 —— | 51万 | 主持的企业/行业委托重大项目 | 主持者 |
| 17 | 药物洗脱球囊进行冠脉原发病变介入治疗术后的多中心研究 | 2021-01 —— | 80万元 | 主持的企业/行业委托重大项目 | 主持者 |
| 18 | 比较冠脉分叉病变介入治疗中常规与积极分支保护策略的前瞻性随机对照研究 | 2016-01 —— | 356万元 | 主持的企业/行业委托重大项目 | 主持者 |
- 发表论文Papers
| # | 论文题目 | 期刊名称 | 发表年份 | 论文署名 |
|---|---|---|---|---|
| 1 | Personalized Early-Warning Signals during Progression of Human Coronary Atherosclerosis by Landscape Dynamic Network Biomarker | Genes (Basel) | 2020-06 | 通讯作者 |
| 2 | Benefit-Risk Profile of DAPT Continuation Beyond 1 Year after PCI in Patients with High Thrombotic Risk Features as Endorsed by 2018 ESC/EACTS Myocardial Revascularization Guideline | Cardiovasc Drugs Ther | 2020-10 | 通讯作者 |
| 3 | Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI | BMC Cardiovasc Disord | 2020-07 | 通讯作者 |
| 4 | Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients | Catheter Cardiovasc Interv | 2020-02 | 通讯作者 |
| 5 | Association of TSR1 Variants and Spontaneous Coronary Artery Dissection | J Am Coll Cardiol | 2019-07 | 通讯作者 |
| 6 | Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation | Catheter Cardiovasc Interv | 2022-01 | 通讯作者 |
| 7 | Optimal Revascularization Strategy for Patients With ST-segment Elevation Myocardial Infarction and Multivessel Disease: A Pairwise and Network Meta-Analysis | Front Cardiovasc Med | 2022-01 | 通讯作者 |
| 8 | Coronary artery bypass graft surgery versus stenting for patients with chronic kidney disease and complex coronary artery disease: a systematic review and meta-analysis | Ther Adv Chronic Dis | 2021-03 | 通讯作者 |
| 9 | A Scoring System to Predict No-Reflow Phenomenon in Elective Percutaneous Coronary Intervention: The RECOVER Score | Curr Probl Cardiol | 2021-03 | 通讯作者 |
| 10 | A Practical Risk Score to Predict 24-Month Post-Discharge Mortality Risk in Patients With Non-ST-Segment Elevation Myocardial Infarction | Circ J | 2020-10 | 通讯作者 |
| 11 | Diffuse coronary artery dilation predicted worse long-term outcomes in patients with coronary artery Ectasia | Int J Cardiol | 2022-11 | 通讯作者 |
| 12 | Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study | J Interv Cardiol | 2020-04 | 通讯作者 |
| 13 | Active Side Branch Protection Versus Conventional Approach to the Protection of High-Risk Side Branches--The CIT-RESOLVE Trial | JACC Cardiovasc Interv | 2022-05 | 通讯作者 |
| 14 | Simple risk score based on the China Acute Myocardial Infarction registry for predicting in-hospital mortality among patients with non-ST-segment elevation myocardial infarction: results of a prospective observational cohort study | BMJ Open | 2019-09 | 通讯作者 |
| 15 | Association between smoking and in-hospital mortality in patients with acute myocardial infarction: results from a prospective, multicentre, observational study in China | BMJ Open | 2019-08 | 通讯作者 |
| 16 | Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction | Front Cardiovasc Med | 2022-02 | 通讯作者 |
| 17 | Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis | Catheter Cardiovasc Interv | 2022-01 | 通讯作者 |
| 18 | Prognostic and Practical Validation of ESC/EACTS High Ischemic Risk Definition on Long-Term Thrombotic and Bleeding Events in Contemporary PCI Patients | J Atheroscler Thromb | 2022-04 | 通讯作者 |
| 19 | Feasibility and safety of robotic PCI in China: first in man experience in Asia | J Geriatr Cardiol | 2019-05 | 通讯作者 |
| 20 | Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction-an analysis from China Acute Myocardial Infarction (CAMI) registry | J Geriatr Cardiol | 2019-05 | 通讯作者 |
| 21 | Can “True Bifurcation Lesion” Really be Regarded as an Independent Risk Factor of Acute Side Branch Occlusion after Main Vessel Stenting | Catheter Cardiovasc Interv | 2016-03 | 通讯作者 |
| 22 | Clinical and Angiographic Characteristics of Premenopausal Women with Coronary Artery Disease | Chin Med J (Engl) | 2008-12 | 通讯作者 |
| 23 | Investigation of novel metabolites potentially involved in the pathogenesis of coronary heart disease using a UHPLC-QTOF/MS-based metabolomics approach | Sci Rep | 2017-07 | 通讯作者 |
| 24 | An angiographic tool for risk prediction of side branch occlusion in coronary bifurcation intervention: the RESOLVE score system (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion) | JACC Cardiovasc Interv | 2015-08 | 通讯作者 |
| 25 | Comparison of long-term clinical outcome after successful implantation of FIREBIRD and CYPHER sirolimus-eluting stents in daily clinical practice:analysis of a large single-center registry | Chin Med J (Engl) | 2011-12 | 通讯作者 |
| 26 | Comparison of long-term clinical outcome after successfulimplantation of Firebird sirolimusand Taxus paclitaxel-eluting stents in Chinese population: analysis of a large single center registry. | Chin Med J (Engl) | 2010-12 | 通讯作者 |
| 27 | Se@SiO2 nanocomposites attenuate doxorubicin-induced cardiotoxicity through combatting oxidative damage | Artif Cells Nanomed Biotechnol | 2018-01 | 通讯作者 |
| 28 | Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion | J Nucl Cardiol | 2018-01 | 通讯作者 |
| 29 | The impact of acquired thrombocytopenia on long‐term outcomes of patients undergoing elective percutaneous coronary intervention: An analysis of 8,271 consecutive patients | Catheter Cardiovasc Interv | 2018-09 | 通讯作者 |
| 30 | Dual-time-point myocardial 18 F-FDG imaging in the detection of coronary artery disease | BMC Cardiovasc Disord | 2017-12 | 通讯作者 |
| 31 | How bifurcation angle impacts the fate of side branch after main vessel stenting: A retrospective analysis of 1,200 consecutive bifurcation lesions in a single center | Catheter Cardiovasc Interv | 2015-12 | 通讯作者 |
| 32 | Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions | J Geriatr Cardiol | 2017-12 | 通讯作者 |
| 33 | An Angiographic Tool Based on Visual Estimation for Risk PrEdiction of Side Branch OccLusion in Coronary Bifurcation InterVEntion: The V-RESOLVE Score System | EuroIntervention | 2016-04 | 通讯作者 |
| 34 | Use of resting myocardial 18F-FDG imaging in the detection of unstable angina | Nucl Med Commun | 2015-10 | 通讯作者 |
| 35 | Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with denovo native coronary artery lesions: the NOYA I trial | EuroIntervention | 2012-08 | 通讯作者 |
| 36 | The Association Between Body Mass Index and In-hospital Outcome Among Patients with Acute Myocardial Infarction—Insights from China Acute Myocardial Infarction | Nutr Metab Cardiovasc Dis | 2019-08 | 通讯作者 |
| 37 | Validating the Performances of Five Risk Scores for Major Adverse Cardiac Events in Patients who Achieved Complete Revascularization after PCI | Can J Cardiol | 2019-08 | 通讯作者 |
| 38 | Development and validation of a risk scoring system based on baseline angiographic results by visual estimation for risk prEdiction of side-branch OccLusion in coronary bifurcation InterVEntion: The baseline V-RESOLVE score | Catheter Cardiovasc Interv | 2019-12 | 通讯作者 |
| 39 | Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients | Catheter Cardiovasc Interv | 2018-12 | 通讯作者 |
| 40 | Is side branch lesion length an independent predictor of acute side branch occlusion in provisional strategy? Analysis of 524 consecutive bifurcation lesions | Catheter Cardiovasc Interv | 2018-09 | 通讯作者 |
| 41 | The Predictive Value of Baseline Target Lesion SYNTAX Score for No-Reflow during Urgent Percutaneous Coronary Intervention in Acute Myocardial Infarction | J Interv Cardiol | 2021-08 | 通讯作者 |
| 42 | Validation of the DAPT score in large-scale consecutive and contemporary patients population in the real world | Platelets | 2021-11 | 通讯作者 |
| 43 | Sleep quality and Risk of Cancer-Findings from the English Longitudinal Study of Ageing | Sleep | 2021-03 | 通讯作者 |
| 44 | Impact of Public Health Emergency Response to COVID-19 on Management and Outcome for NSTEMI Patients in Beijing—a Single-Centre Historic Control | Catheter Cardiovasc Interv | 2021-03 | 通讯作者 |
| 45 | Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI | Platelets | 2021-05 | 通讯作者 |
| 46 | Risk/Benefit Tradeoff of Prolonging Dual Antiplatelet Therapy More Than 12 Months in TWILIGHT-Like High-Risk Patients After Complex Percutaneous Coronary Intervention | Am J Cardiol | 2020-07 | 通讯作者 |
| 47 | Effect of resveratrol combined with atorvastatin on re-endothelialization after drug-eluting stents implantation and the underlying mechanism | Life Sci | 2020-03 | 通讯作者 |
| 48 | Is the SYNTAX Score II applicable in all percutaneous coronary intervention patients? | Catheter Cardiovasc Interv | 2019-02 | 通讯作者 |
| 49 | Prognostic significance of prior ischemic stroke in patients with coronary artery disease undergoing percutaneous coronary intervention | Catheter Cardiovasc Interv | 2019-05 | 通讯作者 |
| 50 | A novel technique for coronary bifurcation intervention: Double rewire crush technique and its clinical outcomes after 2 years of follow-up | Catheter Cardiovasc Interv | 2019-05 | 通讯作者 |
| 51 | Risk Stratification of Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention: Analysis Based on the SCAI Definition | Catheter Cardiovasc Interv | 2017-08 | 通讯作者 |
| 52 | Coronary Bifurcation Intervention: What Role Do Bifurcation Angles Play? | J Interv Cardiol | 2015-02 | 通讯作者 |
| 53 | Clinical and Angiographic Predictors of Major Side Branch Occlusion after Main Vessel Stenting in Coronary Bifurcation Lesions | Chin Med J (Engl) | 2015-12 | 通讯作者 |
| 54 | Can “Hybrid stent implantation” improve long-term safety without adversely affecting efficacy when treating multilesion coronary artery disease in the drug-eluting stent era? | Chin Med J (Engl) | 2013-12 | 通讯作者 |
| 55 | Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry | Chin Med J (Engl) | 2009-03 | 通讯作者 |
| 56 | Jailed Balloon Technique Is Superior to Jailed Wire Technique in Reducing the Rate of Side Branch Occlusion: Subgroup Analysis of the Conventional Versus Intentional StraTegy in Patients With High Risk PrEdiction of Side Branch OccLusion in Coronary Bifur | Front Cardiovasc Med | 2022-03 | 通讯作者 |
| 57 | How Do Lipoprotein(a) Concentrations Affect Clinical Outcomes for Patients With Stable Coronary Artery Disease Who Underwent Different Dual Antiplatelet Therapy After Percutaneous Coronary Intervention? | J Am Heart Assoc | 2022-11 | 通讯作者 |
| 58 | Effects of Diabetes Mellitus on Post-intervention Coronary Physiological Assessment Derived by Quantitative Flow Ratio in patients with Coronary Artery Disease Underwent Percutaneous Coronary Intervention | Diabetes Res Clin Pract | 2022-03 | 通讯作者 |
| 59 | Outcomes of Quantitative Flow Ratio-Based Percutaneous Coronary Intervention in an All-Comers Study | EuroIntervention | 2022-02 | 通讯作者 |
| 60 | Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations | Front Cardiovasc Med | 2021-12 | 通讯作者 |
| 61 | The Effect of a WeChat-Based Tertiary A-Level Hospital Intervention on Medication Adherence and Risk Factor Control in Patients With Stable Coronary Artery Disease: Multicenter Prospective Study | JMIR Mhealth Uhealth | 2021-10 | 通讯作者 |
| 62 | Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCI | JACC Cardiovasc Interv | 2021-08 | 通讯作者 |
| 63 | Gene Expression Analysis Suggests Immunological Changes of Peripheral Blood Monocytes in the Progression of Patients With Coronary Artery Disease | Front Genet | 2021-03 | 通讯作者 |
| 64 | Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study | Nutr Metab Cardiovasc Dis | 2022-04 | 通讯作者 |
| 65 | Thrombotic vs. Bleeding Events of Interruption of Dual Antiplatelet Therapy within 12？Months among Patients with Stent-Driven High Ischemic Risk Definition following PCI | J Interv Cardiol | 2022-01 | 通讯作者 |
| 66 | Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia | Front Cardiovasc Med | 2021-11 | 通讯作者 |
| 67 | Identification of Key Genes as Early Warning Signals of Acute Myocardial Infarction Based on Weighted Gene Correlation Network Analysis and Dynamic Network Biomarker Algorithm | Front Immunol | 2022-06-03 | 通讯作者 |
| 68 | Prognostic Implications of Pre-stent Pullback Pressure Gradient and Post-stent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention | J Am Heart Assoc | 2022-06-03 | 通讯作者 |
| 69 | Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus | Am J Cardiol | 2021-03 | 通讯作者 |
| 70 | Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients | Catheter Cardiovasc Interv | 2021-05 | 通讯作者 |
| 71 | The CAMI-score: A Novel Tool derived From CAMI Registry to Predict In-hospital Death among Acute Myocardial Infarction Patients | Sci Rep | 2022-06-03 | 通讯作者 |
| 72 | Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world | Catheter Cardiovasc Interv | 2018-09 | 通讯作者 |
| 73 | Predictors and Periprocedural Myocardial Injury Rate of Small Side Branches Occlusion in Coronary Bifurcation Intervention | Medicine (Baltimore) | 2015-09 | 通讯作者 |
| 74 | A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow- | Chin Med J (Engl) | 2021-12 | 通讯作者 |
| 75 | Myocardial 18F-FDG Uptake after Exercise-induced Myocardial Ischemia in Patients with Coronary Artery Disease. | J Nucl Med | 2008-04 | 通讯作者 |
| 76 | The CAMI-NSTEMI score: A Novel Tool Derived From CAMI Registry to Predict In-hospital Death of Non-ST Segment Elevation Myocardial Infarction Patients | Catheter Cardiovasc Interv | 2018-08 | 通讯作者 |
| 77 | Validation of the V‐RESOLVE (V isual E stimation for R isk pr E diction of S ide B ranch O cc L usion in C oronary B ifurcation inter VE ntion) score system | Catheter Cardiovasc Interv | 2018-09 | 通讯作者 |
| 78 | A randomised comparison of conventional versus intentional strategy in patients with high risk prediction of side branch occlusion in coronary bifurcation intervention: rationale and design of the cit-resolve trial | BMJ Open | 2017-06 | 通讯作者 |
| 79 | Comparison of procedural and long-term outcomes between transradial and transfemoral approach in one-stage intervention for triple vessel coronary artery disease | J Interv Cardiol | 2014-02 | 通讯作者 |
| 80 | New Insights Into Long- Versus Short-Term Dual Antiplatelet Therapy Duration in Patients After Stenting for Left Main Coronary Artery Disease: Findings From a Prospective Observational Study | Circ Cardiovasc Interv | 2022-06-03 | 通讯作者 |
| 81 | Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality | Int J Cardiol | 2022-04 | 通讯作者 |
| 82 | Effect of type 2 diabetes on coronary artery ectasia: smaller lesion diameter and shorter lesion length but similar adverse cardiovascular events | Cardiovasc Diabetol | 2022-01 | 通讯作者 |
| 83 | Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia. | J Cardiovasc Dev Dis | 2021-12 | 通讯作者 |
| 84 | Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome | Catheter Cardiovasc Interv | 2022-01 | 通讯作者 |
| 85 | Impact of Public Health Emergency Response to COVID-19 on Management and Outcome for STEMI Patients in Beijing—a Single-Centre Historic Control Study | Curr Probl Cardiol | 2021-03 | 通讯作者 |
| 86 | Prognostic Value of Quantitative Flow Ratio Based Functional SYNTAX Score in Patients with Left Main or Multivessel Coronary Artery Disease | Circ Cardiovasc Interv | 2020-10 | 通讯作者 |
| 87 | Sleep Quality and Risk of Coronary Heart Disease—a prospective cohort study from the English Longitudinal Study of Ageing | Aging (Albany NY) | 2020-11 | 通讯作者 |
| 88 | Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China Trial | JACC Cardiovasc Interv | 2022-12 | 通讯作者 |
| 89 | Effect of Thin-Walled Radial Sheath for Large-Bore Access On Reducing Periprocedural Radial Artery Occlusion Following Complex PCI: The REDUCE-RAO Randomized Trial | Rev Cardiovasc Med | 2022-03 | 通讯作者 |
| 90 | High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study | Cardiovasc Diabetol | 2022-08 | 通讯作者 |
| 91 | Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease | J Cardiovasc Dev Dis | 2022-10 | 通讯作者 |
| 92 | Prognostic value of N-terminal Pro-B-Type natriuretic peptide in patients with intermediate coronary lesions | Front Cardiovasc Med | 2022-07 | 通讯作者 |
| 93 | Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry | Front Endocrinol (Lausanne) | 2022-06 | 通讯作者 |
| 94 | Stress hyperglycemia ratio and long-term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry | Diabetes Metab Res Rev | 2022-06 | 通讯作者 |
| 95 | Elevated cardiac troponin I and short-term mortality in patients with acute type A aortic dissection | Eur Heart J Acute Cardiovasc Care | 2022-08 | 通讯作者 |
| 96 | Directly Measured vs. Calculated Low-Density Lipoprotein Cholesterol Does Not Identify Additional Individuals With Coronary Artery Disease and Diabetes at Higher Risk of Adverse Events: Insight From a Large Percutaneous Coronary Intervention Cohort in Asia | Front Cardiovasc Med | 2022-07 | 通讯作者 |
| 97 | Dietary Inflammation Index and Its Association with Long-Term All-Cause and Cardiovascular Mortality in the General US Population by Baseline Glycemic Status | Nutrients | 2022-06 | 通讯作者 |
| 98 | Time Trends of Ventricular Reconstruction and Outcomes among Patients with Left Ventricular Thrombus and Aneurysms | J Cardiovasc Dev Dis | 2022-12 | 通讯作者 |
| 99 | Novel subgroups of patients with left ventricular thrombus and their differential effects with anticoagulation: a data-driven cluster analysis | J Med Internet Res | 2022-11 | 通讯作者 |
| 100 | The impact of sleep quality and its change on the long-term risk of stroke in middle-aged and elderly people: Findings from the English Longitudinal Study of Ageing | Sleep Med | 2023-05 | 通讯作者 |
| 101 | Trends in dietary patterns over the last decade and their association with long-term mortality in general US populations with undiagnosed and diagnosed diabetes | Nutr Diabetes | 2023-04 | 通讯作者 |
| 102 | The value of the MIND diet in the primary and secondary prevention of hypertension: A cross-sectional and longitudinal cohort study from NHANES analysis | Front Nutr | 2023-03 | 通讯作者 |
| 103 | Association of sleep quality, its change and sleep duration with the risk of type 2 diabetes mellitus: Findings from the English longitudinal study of ageing | Diabetes Metab Res Rev | 2023-06 | 通讯作者 |
| 104 | Better adherence to the MIND diet is associated with lower risk of all-cause death and cardiovascular death in patients with atherosclerotic cardiovascular disease or stroke: a cohort study from NHANES analysis | Food Funct | 2023-02 | 通讯作者 |
| 105 | Triglyceride glucose index predicts in-hospital mortality in patients with ST-segment elevation myocardial infarction who underwent primary angiography | J Geriatr Cardiol | 2023-03 | 通讯作者 |
| 106 | The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: a prospective cohort study in Asia | Eur J Prev Cardiol | 2023-03 | 通讯作者 |
| 107 | Fasting stress hyperglycemia ratio and in-hospital mortality after acute myocardial infarction in patients with different glucose metabolism status: Results from China acute myocardial infarction registry | Diabetes Res Clin Pract | 2023-02 | 通讯作者 |
| 108 | Prognostic Value of Machine-Learning-Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | J Am Heart Assoc | 2023-04 | 通讯作者 |
| 109 | Prevalence and prognostic impact of stress-induced hyperglycemia in patients with acute type A aortic dissection | Diabetes Res Clin Pract | 2023-07 | 通讯作者 |
| 110 | High absolute neutrophil count with type 2 diabetes is associated with adverse outcome in patients with coronary artery disease: A large-scale cohort study | Front Endocrinol (Lausanne) | 2023-04 | 通讯作者 |
| 111 | Diabetes Mellitus with Mild or Moderate Kidney Dysfunction is Associated with Poor Prognosis in Patients with Coronary Artery Disease: A Large-Scale Cohort Study | Diabetes Res Clin Pract | 2023-05 | 通讯作者 |
| 112 | Trends in Cardiovascular Risk Factors Control Among US Adults by Glycemic Statuses, 2007-2018 | Eur J Prev Cardiol | 2023-03 | 通讯作者 |
| 113 | The Combined Effect of Systemic Immune-Inflammation Index and Type 2 Diabetes Mellitus on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Cohort Study | J Inflamm Res | 2023-12 | 通讯作者 |
| 114 | High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study | Cardiovasc Diabetol | 2023-07 | 通讯作者 |
| 115 | Association Between MIND Diet Adherence and Mortality: Insights from Diabetic and Non-Diabetic Cohorts | Nutr Diabetes | 2023-10 | 通讯作者 |
| 116 | Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia | J Am Heart Assoc | 2023-10 | 通讯作者 |
| 117 | The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry | Cardiovasc Diabetol | 2023-07 | 通讯作者 |
| 118 | Time Trends of Etiology, Treatment, and Long-Term Outcomes Among Patients with Left Ventricular Thrombus | Rev Cardiovasc Med | 2023-02 | 通讯作者 |
| 119 | Current Evidence in the Diagnosis and Management of Coronary Arteritis Presenting as Acute Coronary Syndrome | Curr Probl Cardiol | 2023-02 | 通讯作者 |
| 120 | HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study | Cardiovasc Diabetol | 2023-03 | 通讯作者 |
| 121 | Feasibility and Safety of Drug-Coated Balloon for Treatment of De Novo Coronary Artery Lesions in Large Vessel Disease: A Large-Scale Multicenter Prospective Study | Rev Cardiovasc Med | 2023-10 | 通讯作者 |
| 122 | Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions | Cardiovasc Diabetol | 2023-06 | 通讯作者 |
| 123 | Prolonged Dual Antiplatelet Therapy in Invasively Treated Acute Coronary Syndrome Patients with Different Lipoprotein(a) Concentrations | Cardiol J | 2023-10 | 通讯作者 |
| 124 | Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes | J Endocrinol Invest | 2023-09 | 通讯作者 |
| 125 | Social isolation, loneliness, and incident type 2 diabetes mellitus: results from two large prospective cohorts in Europe and East Asia and Mendelian randomization | EClinicalMedicine | 2023-09 | 通讯作者 |
| 126 | High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study | Cardiovasc Diabetol | 2023-10 | 通讯作者 |
| 127 | Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status | Nutr Metab Cardiovasc Dis | 2024-04 | 通讯作者 |
| 128 | Triglyceride-glucose index as a suitable non-insulin-based insulin resistance marker to predict cardiovascular events in patients undergoing complex coronary artery intervention: a large-scale cohort study | Cardiovasc Diabetol | 2024-01 | 通讯作者 |
| 129 | Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study | Cardiovasc Diabetol | 2024-01 | 通讯作者 |
| 130 | Discordance Between Neutrophil to Lymphocyte Ratio and High Sensitivity C-Reactive Protein to Predict Clinical Events in Patients with Stable Coronary Artery Disease: A Large-Scale Cohort Study | J Inflamm Res | 2023-11 | 通讯作者 |
| 131 | Association of platelet-to-lymphocyte ratio levels with the risk of cardiac adverse events in people with type 2 diabetes undergoing percutaneous coronary intervention: A large-scale prospective cohort study | Diabetes Metab Syndr | 2024-03 | 通讯作者 |
| 132 | The Neutrophil to Lymphocyte Ratio Modifies Lipoprotein (a)-Related Poor Prognosis in Patients After Percutaneous Coronary Intervention | Angiology | 2024-05 | 通讯作者 |
| 133 | Identifying Cardiomyocyte Ploidy With Nuclear Area and Volume | Circulation | 2024-05 | 通讯作者 |
| 134 | A new scoring system predicting side branch occlusion in patients undergoing left main bifurcation intervention: the LM V-RESOLVE score | Can J Cardiol | 2024-02 | 通讯作者 |
| 135 | Molecular Imaging of Fibroblast Activation in Rabbit Atherosclerotic Plaques: a Preclinical PET/CT Study | Mol Imaging Biol | 2024-04 | 通讯作者 |
| 136 | High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study | Cardiovasc Diabetol | 2024-06 | 通讯作者 |
| 137 | Association of acute glycemic parameters at admission with cardiovascular mortality in the oldest old with acute myocardial infarction | J Geriatr Cardiol | 2024-03 | 通讯作者 |
| 138 | Triiodothyronine induces a proinflammatory monocyte/macrophage profile and impedes cardiac regeneration | J Mol Cell Cardiol | 2024-06 | 通讯作者 |
| 139 | Left main bifurcation stenting: impact of residual ischaemia on cardiovascular mortality | Eur Heart J | 2024-11 | 通讯作者 |
- 科研获奖Research Awards
| # | 获奖证书编号 | 奖项名称 | 获奖级别 | 获奖类别 | 获奖等级 | 获奖日期 | 颁奖单位 | 本单位是否为第一完成单位 | 完成单位排名 | 本人排序 | 备注 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 201202110P1006 | 中华医学科技奖 | 省部级 | 其他省部级奖励 | 二等奖 | 2012-12-18 | 中华医学会 | 是 | 1 | 6 | |
| 2 | 2014医-3-014 | 北京市科学技术奖 | 省部级 | 省（市、自治区）政府自然科学奖、技术发明奖 | 三等奖 | 2014-12-01 | 北京市人民政府 | 是 | 1 | 3 | |
| 3 | 2021-Z-1-003 | 山西省科学技术奖 | 省部级 | 省（市、自治区）政府自然科学奖、技术发明奖 | 一等奖 | 2021-12-01 | 山西省科学技术奖励委员会 | 否 | 3 | 3 | |
| 4 | 2010-107 | 高等学校科学研究优秀成果奖 | 省部级 | 教育部高校科研成果奖（科学技术、人文社科） | 二等奖 | 2011-12-15 | 中华人民共和国教育部 | 是 | 1 | 3 | |
| 5 | 201402026P0605 | 中华医学科技奖 | 省部级 | 其他省部级奖励 | 二等奖 | 2014-12-29 | 中华医学会 | 是 | 1 | 5 | |
| 6 | 20104492-1-R14 | 上海市科学技术奖 | 省部级 | 省（市、自治区）政府自然科学奖、技术发明奖 | 一等奖 | 2010-11-03 | 上海市人民政府 | 是 | 1 | 13 | |
| 7 | 2010-230 | 高等学校科学研究优秀成果奖 | 省部级 | 教育部高校科研成果奖（科学技术、人文社科） | 二等奖 | 2011-12-15 | 中华人民共和国教育部 | 是 | 1 | 13 |
- 研究成果Research Findings
| # | 成果类型 | 项目/专利/新品种名称 |
|---|---|---|
| 1 | 作为主创人员获得授权的发明专利和新品种 | 经桡动脉介入超滑导丝 |
| 2 | 作为主创人员获得授权的发明专利和新品种 | 经桡动脉介入造影导丝 |
| 3 | 出版高水平专著 | 心血管介入治疗高级培训教程 |
| 4 | 出版高水平专著 | 专家解读冠心病 |
| 5 | 出版高水平专著 | 阜外医院心血管病学专科医师规范化培训教程 |
| 6 | 作为主创人员获得授权的发明专利和新品种 | 用于血管介入手术机器人的球囊导管驱动装置 |
| 7 | 作为主创人员获得授权的发明专利和新品种 | 用于血管介入手术机器人的导管旋转驱动装置 |
| 8 | 作为主创人员获得授权的发明专利和新品种 | 一种冠脉左主干分叉的分支闭塞风险预测方法及系统 |
| 9 | 作为主创人员获得授权的发明专利和新品种 | 一种造影导丝 |
| 10 | 作为主创人员获得授权的发明专利和新品种 | 用于血管介入手术机器人的动力单元 |